Company: NKLR
Filing Date: 2025-09-16
Form Type: 424B3
Source: 0001213900-25-087981
Chunk: 323

Company: Terra Innovatum Global N.V.
Filing Date: 2025-09-16
Form: 424B3
Chunk 323
---
 | Potential Patent 
 Expiration       |
| Small And Micro Nuclear Reactors And Conductive Solid Moderator Assemblies With Embedded Nuclear Fuel Used Therein |     | 8/25/2024 |     | 8/25/2025   |     | 8/25/2045        |
| Control And Shutdown System For Small And Micro Nuclear Reactors                                                   |     | 8/25/2024 |     | 8/25/2025   |     | 8/25/2045        |
| Control And Shutdown System For Small And Micro Nuclear Reactors                                                   |     | 1/10/2025 |     | 1/10/2026   |     | 1/10/2046        |
| Small and Micro Nuclear Reactor with Real Time Integrated Safeguard Systems                                        |     | 1/13/2025 |     | 1/13/2026   |     | 1/13/2046        |
| Reactor Vessel Shell And Integrated Radiological Containment For Small And Micro Nuclear Reactors                  |     | 4/20/2025 |     | 4/20/2026   |     | 4/20/2046        |
| Radioisotopes Production with Nuclear Micro-Reactor                                                                |     | 4/20/2025 |     | 4/20/2026   |     | 4/20/2046        |

163 We also engage with international and local regulatory bodies and existing frameworks to safeguard our innovations across various jurisdictions. However, certain countries where our reactor components may be manufactured or where our reactor systems may be deployed may offer less robust protection for nuclear intellectual property compared to the United States or European Union regulatory environments. Our intellectual property strategy employs a systematic assessment framework considering: —Critical component manufacturing locations and supply chain considerations; —Strategic nuclear technology development pathways across different regulatory regimes; —Nuclear -specificintellectual property enforcement mechanisms in target deployment jurisdictions; and —Commercial significance relative to established and emerging competitors in specific nuclear markets and regions. We plan to establish licensing agreements for certain specialized nuclear technologies from third -partydevelopers and anticipate continued expansion of such arrangements as our reactor deployment roadmap advances. Manufacturing and supply chain We implement a fabless and contract manufacturing strategy, and expect to contract with key suppliers for all phases of the manufacturing process. We leverage the expertise of industry -leadingsuppliers that comply with nuclear quality assurance standards — including 10 CFR 50 Appendix B